NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -98.2% | 2,550 | -94.8% | 0.01% | -98.2% |
| Q2 2022 | $2,530,000 | -32.0% | 49,200 | -2.6% | 0.51% | -22.7% |
| Q1 2022 | $3,719,000 | -41.3% | 50,500 | +14.0% | 0.66% | -30.8% |
| Q4 2021 | $6,338,000 | -65.8% | 44,300 | -50.5% | 0.95% | -38.1% |
| Q3 2021 | $18,544,000 | -1.3% | 89,450 | +1.1% | 1.54% | +1.5% |
| Q2 2021 | $18,779,000 | -45.8% | 88,450 | -53.7% | 1.52% | -42.2% |
| Q1 2021 | $34,666,000 | +39.2% | 191,200 | -14.4% | 2.63% | +49.7% |
| Q4 2020 | $24,906,000 | +94.5% | 223,350 | +89.0% | 1.76% | +59.4% |
| Q3 2020 | $12,807,000 | – | 118,200 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |